Visit the Cole-Parmer UK web site
Key to icons
  • Video icon Video
  • Info icon Company news
  • Product icon Product news
  • Download icon Downloads
  • Casestudy icon Application news
  • Datasheet icon Technical Articles

Microbix Biosystems

All articles from Microbix Biosystems

Microbix Biosystems - Latest company news

27 October 2009 - Microbix has signed an agreement with the Hunan Biopharmaceutical Company for initial financing to construct Asia's largest influenza vaccine production facility.

News from Laboratorytalk, 28 October 2009

Microbix announces changes to board of directors

Vaughn Embro-Pantalony has been appointed to the board of directors, replacing James A Long who has assumed his duties as chief financial officer, and has resigned as a director

News from Laboratorytalk, 15 February 2007

Semen-sexing system has market potential

Technology can separate male-producing sperm from female-producing sperm, thus ensuring the desired sex of offspring for use in commercial cattle and swine livestock production

News from Laboratorytalk, 5 October 2005

Flu technology attracts interest

Microbix enters exclusive review and negotiation period for proprietary influenza virus yield enhancement technology

News from Laboratorytalk, 23 June 2004

Patent filed for new vaccine technology platform

New proprietary vaccine technology platform is said to have the potential to offer significant economic advantages to vaccine producers

News from Laboratorytalk, 2 July 2003

Microbix raises financing to continue development

Microbix Biosystems has announced that it has completed a Canadian $500,000 Principal amount 8% convertible debenture, in a non-arms length transaction with an existing shareholder.

News from Laboratorytalk, 24 December 2002

Mystery partner in urokinase deal

Generic version of Abbott's urokinase drug Abbokinase, for the treatment of pulmonary embolism or lung blood clots, to be developed in agreement with secretive partner

News from Laboratorytalk, 22 November 2002

Agreement on adenovirus vector technology

Helper-dependent (HD) adenovirus vectors are being studied at the basic research level as potential tools for gene therapy and drug delivery

News from Laboratorytalk, 19 November 2002

Successful third quarter

Microbix Biosystems reports profitable third quarter and 19% rise in sales

News from Laboratorytalk, 30 August 2002

Biotech exec joins the board

Microbix biosystems announces the addition of a biotechnology executive Patrick Walsh to its board of directors

News from Laboratorytalk, 2 August 2002

New York panel on generic biologics

Generic Pharmaceutical Association's workshop on regulatory and legislative issues hears industry views on characterisation of active pharmaceutical ingredients

News from Laboratorytalk, 22 March 2002

Microbix on generic biologics panel

Microbix Biosystems will participate in a four-member FDA-sponsored panel to address issues of comparability and equivalence at the 6th WCBP Symposium in Washington

News from Laboratorytalk, 5 February 2002

TransAtlantic cell evolution

Nautilus Biotech of France and Microbix Biosystems of Canada announce a distribution agreement for academic applications of NautCell, a high-producer cell-line for recombinant Adeno-associated vectors

News from Laboratorytalk, 30 January 2002

Featured articles

Contact

Back to topBack to top

Visit the Cole-Parmer UK web site
New Video Newsletter

All suppliers A - Z

A Pro-talk Publication

A Pro-talk publication